Incanthera (AQSE:INC) Accounts Payable : £0.63 Mil (As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Incanthera Accounts Payable?

Incanthera's Accounts Payable for the quarter that ended in Sep. 2023 was £0.63 Mil.

Incanthera's quarterly Accounts Payable declined from Sep. 2022 (£0.20 Mil) to Mar. 2023 (£0.15 Mil) but then increased from Mar. 2023 (£0.15 Mil) to Sep. 2023 (£0.63 Mil).

Incanthera's annual Accounts Payable increased from Mar. 2021 (£0.12 Mil) to Mar. 2022 (£0.20 Mil) but then declined from Mar. 2022 (£0.20 Mil) to Mar. 2023 (£0.15 Mil).

Incanthera Accounts Payable Historical Data

The historical data trend for Incanthera's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Incanthera Accounts Payable Chart

Incanthera Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Accounts Payable

0.05

0.12

0.20

0.15

Incanthera Semi-Annual Data
	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Accounts Payable	Get a 7-Day Free Trial			0.24	0.20	0.20	0.15	0.63

Incanthera Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Incanthera Accounts Payable Related Terms

Thank you for viewing the detailed overview of Incanthera's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Incanthera (AQSE:INC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Incanthera PLC (AQSE:INC) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

76 King Street, Manchester, GBR, M2 4NH

Website

http://www.incanthera.com

Incanthera PLC is a specialist dermatology and oncology company focused on transforming cancer treatment by creating environments in which cancer cannot survive. It identifies and develops solutions to current clinical, commercially relevant unmet needs, utilising a new technology. The company's current products are Sol, EP0015, Equin and Duo-C. The company has one segment, namely the development of pharmaceutical products all within the United Kingdom.

Incanthera (AQSE:INC) Headlines

No Headlines